Research Topics
| Daisuke NonakaSummaryAffiliation: Istituto Nazionale Tumori Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Cylindroma of the breast of skin adnexal type: a study of 4 casesDaisuke Nonaka
Department of Pathology, National Cancer Institute, Via G Venezian 1, 20133 Milan, Italy
Am J Surg Pathol 28:1070-5. 2004..This is the second reported case of this hereditary syndrome with extracutaneous manifestations and the first case in which the breast is involved...- Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)Dario Baratti
Department of Surgery, National Cancer Institute, Milan, Italy
Ann Surg Oncol 15:526-34. 2008..We reviewed our 10-year monoinstitutional case series to identify selection factors predicting postoperative outcome... - Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patientsAndrea Anichini
Unit of Human Tumors Immunobiology and Department of Pathology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Cancer Res 66:6405-11. 2006..These results suggest that quantitative variations in APM component and HLA expression in melanoma lesions from AJCC stage III and IV patients may have an effect on the clinical course of the disease... - Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusionMarcello Deraco
Department of Surgery, National Cancer Institute, Via Venezian, 1, 20133, Milan, Italy
Ann Surg Oncol 13:229-37. 2006..We performed a prognostic analysis in a cohort of DMPM patients treated homogeneously by cytoreductive surgery and intraperitoneal hyperthermic perfusion (IPHP)... - Thymic mucoepidermoid carcinomas: a clinicopathologic study of 10 cases and review of the literatureDaisuke Nonaka
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Am J Surg Pathol 28:1526-31. 2004..Among these variants, thymic mucoepidermoid carcinomas morphologically similar to the homonymous salivary gland counterparts are particularly unusual; only 9 cases for which clinicopathologic features were available have been reported... 
Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapyDario Baratti
Departments of Surgery, National Cancer Institute, Milan, Italy
Ann Surg 249:243-9. 2009..To investigate outcome and prognostic factors in patients with pesudomyxoma peritonei (PMP) treated by complete cytoreduction and hyperthermic intraperitoneal chemotherapy...- Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institutionDaisuke Nonaka
Department of Pathology, National Cancer Institute, Milan, Italy
Cancer 104:2181-8. 2005..In the current study, the authors report the clinicopathologic features of patients with peritoneal diffuse malignant mesothelioma (DMM) who were treated in a uniform fashion at a single institution to assess prognostic factors... - Undifferentiated large cell carcinoma of the thymus associated with Castleman disease-like reaction: a distinctive type of thymic neoplasm characterized by an indolent behaviorDaisuke Nonaka
Department of Pathology, National Cancer Institute, Milan, Italy
Am J Surg Pathol 29:490-5. 2005..The first hypothesis is favored, with the added suggestion that the CD-like reaction may bear a relationship to the peculiarly indolent behavior that these tumors exhibit... - Constitutive expression and costimulatory function of LIGHT/TNFSF14 on human melanoma cells and melanoma-derived microvesiclesRoberta Mortarini
Human Tumor Immunobiology Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy
Cancer Res 65:3428-36. 2005..These data suggest that LIGHT constitutively expressed in human melanoma cells and microvesicles may contribute to regulate T-cell responses to tumor cells... - A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patientsLorenzo Pilla
Unit of Immunotherapy of Human Tumors, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy
Cancer Immunol Immunother 55:958-68. 2006..Clinical activity was limited to SD. However, both immunological and clinical responses were not improved as compared with those recorded in a previous study investigating HSPPC-96 monotherapy... - Combined high-grade basal cell carcinoma and malignant melanoma of the skin ("malignant basomelanocytic tumor"): report of two cases and review of the literatureJaime Rodriguez
Department of Pathology, National Cancer Institute, Milan, Italy
Am J Dermatopathol 27:314-8. 2005..We favor the hypothesis of a tumor with bidirectional keratinocytic and melanocytic differentiation, an exceptionally rare event... - Apoptotic and cell cycle regulatory markers in uterine leiomyosarcomaAliza L Leiser
Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Gynecol Oncol 101:86-91. 2006.... - Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomasDaisuke Nonaka
Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
Am J Surg Pathol 32:1566-71. 2008.... - Sox10: a pan-schwannian and melanocytic markerDaisuke Nonaka
Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
Am J Surg Pathol 32:1291-8. 2008..Our results indicate that Sox10 will serve as a more sensitive and specific marker for the diagnosis of melanocytic and schwannian tumors than S100 protein... 
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvantSylvia Adams
Department of Medicine, Division of Medical Oncology, New York University Cancer Institute, School of Medicine, New York, NY 10016, USA
J Immunol 181:776-84. 2008..Imiquimod's adjuvant effects require further evaluation and likely need optimization of parameters such as formulation, dose, and timing relative to Ag exposure for maximal immunogenicity...- PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neckLuc G Morris
Head and Neck Surgery Service, New York University Cancer Institute, New York, New York
Head Neck 30:771-5. 2008..Histologic diagnosis of mucosal melanoma of the head and neck is difficult, requiring immunohistochemical stains which are less reliable than in cutaneous lesions. PNL-2 is a novel marker that has not been examined in mucosal melanoma... - NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patientsCristina Maccalli
Unit of Immunotherapy of Human Tumors, Istituto Nazionale Tumori, Milan, Italy
Clin Cancer Res 13:7459-68. 2007..The role of NKG2D receptor in antitumor immunosurveillance has not been completely clarified. We addressed this issue by investigating the involvement of this receptor in tumor-specific immunologic response in melanoma patients... - Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcomaMario M Leitao
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Cancer 101:1455-62. 2004..ER, PR, and AR expression was observed in approximately 30-40% of uterine LMS cases. In the current series, PR and AR expression appeared to be associated with disease-free survival but were not found to correlate with overall survival... - Extraneural hemangioblastoma: a report of 5 casesDaisuke Nonaka
Department of Pathology, New York University Medical Center, 560 First Avenue, New York, NY 10016, USA
Am J Surg Pathol 31:1545-51. 2007.... - Immunohistochemical evaluation of necrotic malignant melanomasDaisuke Nonaka
Department of Pathology, New York University Medical Center, New York, NY 10016, USA
Am J Clin Pathol 127:787-91. 2007..Our study demonstrated that a combination of antibodies to HMB-45, tyrosinase, and PNL2 detected melanocytic differentiation in necrotic areas in 80% of cases... - Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasmsDaisuke Nonaka
Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
Am J Surg Pathol 31:1038-44. 2007..CD205 is a sensitive and specific marker for thymoma but its sensitivity to thymic carcinoma is lower than CD5 and CD117...